| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |